Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

NCT00589563

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

NCT00445731

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
Locations: Not specified

View Trial Details

Completed

Imaging Young Myeloma (IMAgerie JEune Myélome)

NCT01309334

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Bordeaux University Hospital Bordeaux, France

Brest University Hospital "CHU du Morvan" Brest, France

Hospital "Côte de Nacre" Caen, France

Clermont-Ferrand University Hospital Clermont-Ferrand, France

View all 17 locations

View Trial Details

Completed

Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy

NCT00691704

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma

NCT00813150

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Augsburg, Germany

Berlin, Germany

Bielefeld, Germany

Bremerhaven, Germany

View all 40 locations

View Trial Details

Completed

RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma

NCT00729638

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

NCT00621452

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +38 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00110071

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy

NCT00972959

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Department of Clinical Therapeutics, University of Athens School of Medicine, "Alexandra" General Hospital Athens, Greece

Department of Hematology & Medical Research, 251 General Air Force Hospital Athens, Greece

Department of Hematology, "Theagenion" Cancer Center Thessaloniki, Greece

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions